Keywords: واکسن آنفولانزای همه گیر; ATT; abnormal toxicity test; HA; hemagglutinin; IFN; interferon; LTT; leukopenic toxicity test; PDv; pandemic influenza vaccine; PLT; platelet; RE; toxicity reference; SA; saline; WBC; white blood cell; WPv; whole virion preparation of inactivated influen
مقالات ISI واکسن آنفولانزای همه گیر (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: واکسن آنفولانزای همه گیر; panINFLU; 2009/2010 pandemic H1N1 influenza; sINFLU; 2008/2009 seasonal influenza; pH1N1; Pandemic influenza vaccine; Seasonal influenza vaccine; Healthcare workers; Qualitative analysis; Content analysis;
Keywords: واکسن آنفولانزای همه گیر; Technology transfer; Oil-in-water adjuvant; Pandemic influenza vaccine; Vaccine formulation;
Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: Chicago, USA, 23-24 August 2016
Keywords: واکسن آنفولانزای همه گیر; Influenza; Pandemic influenza vaccine; Seasonal influenza vaccine; Universal influenza vaccine; Vaccine development; Nextgeneration influenza vaccine; ADCC; Antibody-dependent cell-mediated cytotoxicity; AE; Adverse event; CMI; cell-mediated immunity; CON
Patterns of spontaneous reports on narcolepsy following administration of pandemic influenza vaccine; a case series of individual case safety reports in Eudravigilance
Keywords: واکسن آنفولانزای همه گیر; ADR; Adverse Drug Reaction; AESI; Adverse Events of Special Interest; BC; Brighton Collaboration; ABC-tool; Automated Brighton Collaboration Case definition tool; EMA; European Medicines Agency; EU/EEA; European Union/European Economic Area; HCP; Health C
Clinical testing of an inactivated influenza A/H5N1 vaccine candidate in a double-blinded, placebo-controlled, randomized trial in healthy adults in Vietnam
Keywords: واکسن آنفولانزای همه گیر; Pandemic influenza vaccine; Vietnam; IVAC; Clinical trial;
Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Geneva, Switzerland, 5-7 May 2014
Keywords: واکسن آنفولانزای همه گیر; ADCC; antibody-dependent cell-mediated cytotoxicity; CMI; cell-mediated immunity; COBRA; computationally optimized broadly reactive antigen; CoP; immune correlate of protection; HA; influenza haemagglutinin protein; HI; haemagglutination inhibition; IFN;
Beta-defensin 2 enhances immunogenicity and protection of an adenovirus-based H5N1 influenza vaccine at an early time
Keywords: واکسن آنفولانزای همه گیر; Adenovirus; Avian influenza; Adenovirus vector-based vaccines; Influenza; Pandemic influenza vaccine; Murine beta-defensin 2;
The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: A capture-recapture analysis
Keywords: واکسن آنفولانزای همه گیر; Pandemic influenza vaccine; Vaccine safety; Postmarketing surveillance; Spontaneous reporting; Taiwan;
Insect cell-expressed hemagglutinin with CpG oligodeoxynucleotides plus alum as an adjuvant is a potential pandemic influenza vaccine candidate
Keywords: واکسن آنفولانزای همه گیر; Pandemic influenza vaccine; CpG oligodeoxynucleotides (CpG-ODN); Adjuvant;
Adverse events associated with pandemic influenza vaccines: Comparison of the results of a follow-up study with those coming from spontaneous reporting
Keywords: واکسن آنفولانزای همه گیر; Pandemic influenza vaccine; Safety; Adverse events; Spontaneous reporting; Follow-up study
Guillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: Self-controlled case series
Keywords: واکسن آنفولانزای همه گیر; GBS; Guillain-Barré syndrome; ILI; influenza like illness; HES; hospital episode statistics; RI; relative incidence; BNSU; British Neurological Surveillance Unit; HPA; Health Protection Agency; ICD; international classification of diseases; Guillain-